The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52
Last updated 2023-01-18
Summary
The study is being done to identify types of bacteria associated with the lining of the large intestine in people who have recently been treated for C. difficile infection to determine if there are features associated with recurrent disease.
Conditions
- Clostridioides Difficile Infection
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Purna Kashyap, MD · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-23
- Primary Completion
- 2022-05-05
- Completion
- 2022-05-05
Countries
- United States
Study Locations
More Related Trials
-
PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA
NCT04259931 ·Status: UNKNOWN
-
LMN-201 for Prevention of C. Difficile Infection Recurrence
NCT05330182 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
NCT07250724 ·Status: RECRUITING
-
Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea
NCT01868373 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
MTC Versus FMT in for RCDI
NCT05911997 ·Status: RECRUITING ·Phase: PHASE1
-
Mucosal and Microbiota Changes During Acute Campylobacteriosis
NCT03223077 ·Status: RECRUITING
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Gut Microbiota and Its Associated Resistome in FMT Donors and Recipients Due to Recurrent Clostridiodes Difficile Infection
NCT06533800 ·Status: NOT_YET_RECRUITING
-
FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI
NCT02255305 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma
NCT06107569 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Clostridioides Difficile Controlled Human Infection Model
NCT06702345 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea
NCT00304876 ·Status: COMPLETED
-
Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection
NCT01259726 ·Status: COMPLETED ·Phase: PHASE2
-
Pathogenic Mechanisms in C Diff Infection and Colitis
NCT01930032 ·Status: COMPLETED
-
Study on Clostridium Difficile Infection in Chinese Patients With Inflammatory Bowel Disease
NCT04179201 ·Status: UNKNOWN
-
FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach
NCT06071312 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Gut Microbiota Changes After Fecal Microbiota Transplantation
NCT02557685 ·Status: UNKNOWN ·Phase: PHASE2
-
Early FMT for C.Difficile
NCT02465463 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Host Immune Response to Clostridium Difficile Infection (ICD)
NCT02440438 ·Status: COMPLETED ·Phase: NA
-
Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)
NCT03005379 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)
NCT01716533 ·Status: COMPLETED ·Phase: NA
-
Studies of the Human Microbiome in Clinical Center Patients
NCT01933620 ·Status: ENROLLING_BY_INVITATION
-
Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection
NCT02403622 ·Status: TERMINATED ·Phase: PHASE2
-
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis
NCT01973465 ·Status: UNKNOWN ·Phase: NA
-
Mucosal Versus Fecal Microbiota in FMT
NCT02133651 ·Status: COMPLETED